Holen Sie sich die Stockscreener-App
61.08
0.91%
-0.56
Vorhandelsmarkt:
61.40
0.32
+0.52%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$61.64
Offen:
$61.09
24-Stunden-Volumen:
6.68M
Relative Volume:
0.79
Marktkapitalisierung:
$77.27B
Einnahmen:
$378.96B
Nettoeinkommen (Verlust:
$5.28B
KGV:
14.58
EPS:
4.19
Netto-Cashflow:
$5.94B
1W Leistung:
-4.47%
1M Leistung:
-8.25%
6M Leistung:
+15.27%
1J Leistung:
+4.71%
1-Tages-Spanne:
$60.86
$62.20
1-Wochen-Bereich:
$60.86
$64.71
52-Wochen-Spanne:
$43.56
$72.51
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
61.08 | 80.89B | 378.96B | 5.28B | 5.94B | 4.19 |
|
UNH
Unitedhealth Group Inc
|
285.13 | 264.62B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
300.05 | 80.79B | 254.47B | 5.03B | 6.01B | 18.06 |
|
ELV
Elevance Health Inc
|
281.72 | 75.71B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
231.12 | 26.78B | 117.76B | 1.21B | 2.39B | 9.95 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
CVS Health Corporation (NYSE:CVS) Shares Sold by KLP Kapitalforvaltning AS - MarketBeat
CVS Health Corporation (NYSE:CVS) Shares Sold by Choreo LLC - MarketBeat
J.W. Cole Advisors Inc. Makes New Investment in CVS Health Corporation (NYSE:CVS) - MarketBeat
CVS hit with class action lawsuit over unwanted telemarketing texts - Class Action Lawsuits
UBS Group Issues Pessimistic Forecast for CVS Health (NYSE:CVS) Stock Price - MarketBeat
DSN announces 2025 Top Women in Health, Wellness & Beauty winners - Drug Store News
VCI Wealth Management LLC Sells 15,326 Shares of CVS Health Corporation (NYSE:CVS) - MarketBeat
CVS Health's Q2 2025 Earnings: What to Expect - MSN
CVS Health stock price target lowered to $67 at UBS on insurance challenges - Investing.com Canada
Here's Why CVS Health (CVS) is Poised for a Turnaround After Losing 7.7% in 4 Weeks - Yahoo.co
CVS Health Has Become A Strong GARP Pick (Rating Upgrade) - Seeking Alpha
AustralianSuper Pty Ltd Has $54.13 Million Stake in CVS Health Corporation (NYSE:CVS) - MarketBeat
Copperwynd Financial LLC Grows Stock Holdings in CVS Health Corporation (NYSE:CVS) - MarketBeat
Legacy Capital Wealth Partners LLC Invests $283,000 in CVS Health Corporation (NYSE:CVS) - MarketBeat
AMG National Trust Bank Has $7.42 Million Holdings in CVS Health Corporation (NYSE:CVS) - MarketBeat
Jennison Associates LLC Grows Position in CVS Health Corporation (NYSE:CVS) - MarketBeat
Graypoint LLC Increases Stock Holdings in CVS Health Corporation (NYSE:CVS) - MarketBeat
CVS Health Corporation (NYSE:CVS) Position Reduced by Victory Capital Management Inc. - MarketBeat
Lobbying Update: $1,810,000 of CVS HEALTH (AND SUBSIDIARIES) lobbying was just disclosed - Quiver Quantitative
What drives CVS Health Corporation stock priceFree Wealth Planning Blueprint - Autocar Professional
CVS and Archer-Daniels-Midland Look Good on This Ratio - TradingView
CVS And Archer-Daniels-Midland Look Good On This Ratio - Forbes
OneAscent Financial Services LLC Has $792,000 Stake in CVS Health Corporation (NYSE:CVS) - MarketBeat
CVS Health Corporation (NYSE:CVS) Shares Sold by Whittier Trust Co. - MarketBeat
Commerzbank Aktiengesellschaft FI Sells 48,815 Shares of CVS Health Corporation (NYSE:CVS) - MarketBeat
CVS Health Corporation (NYSE:CVS) Holdings Reduced by Morningstar Investment Services LLC - MarketBeat
Kingsview Wealth Management LLC Decreases Stock Holdings in CVS Health Corporation (NYSE:CVS) - MarketBeat
CVS Health Corporation Stock Analysis and ForecastFree Stock Market Trend Analysis - jammulinksnews.com
Pzena Investment Management LLC Sells 1,928,205 Shares of CVS Health Corporation (NYSE:CVS) - MarketBeat
What analysts say about CVS Health Corporation stockHigh-profit stock alerts - jammulinksnews.com
CVS Health Corporation (NYSE:CVS) Stock Holdings Decreased by Sigma Planning Corp - MarketBeat
Lobbying Update: $105,000 of CVS HEALTH lobbying was just disclosed - Quiver Quantitative
CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake? - MSN
7,248 Shares in CVS Health Corporation (NYSE:CVS) Bought by Sage Mountain Advisors LLC - MarketBeat
Wealthfront Advisers LLC Grows Stock Holdings in CVS Health Corporation (NYSE:CVS) - MarketBeat
Mountain Hill Investment Partners Corp. Has $28,000 Stake in CVS Health Corporation (NYSE:CVS) - MarketBeat
Catalyst Financial Partners LLC Takes $322,000 Position in CVS Health Corporation (NYSE:CVS) - MarketBeat
CVS Health’s (CVS) Dividend Outlook: Can the Retail-Pharma Giant Deliver in 2025? - Insider Monkey
14 Best Pharma Dividend Stocks to Buy in 2025 - Insider Monkey
CVS Health (CVS) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Everyone Hates Locked Shelves. Even the Retailers. - Bloomberg.com
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
What makes CVS Health Corporation stock price move sharplySmall Risk Large Return Trades - beatles.ru
Bleakley Financial Group LLC Has $3.38 Million Stock Holdings in CVS Health Corporation (NYSE:CVS) - MarketBeat
$95M Caremark Verdict Should Put PBMs On Notice - Law360
3,967 Shares in CVS Health Corporation (NYSE:CVS) Purchased by Kathmere Capital Management LLC - MarketBeat
The National Observer: Pharmacies closing at an alarming rate - The Business Journals
Cwm LLC Grows Position in CVS Health Corporation (NYSE:CVS) - MarketBeat
CVS Pharmacy at busy Phoenix intersection to close; plus 7 more Valley deals to know - The Business Journals
CVS Health's Q2 2025 Earnings: What To Expect - Barchart.com
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):